MétaCan
Menu
Back to cohort
Record W2735667632 · doi:10.1016/j.kint.2017.04.019

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference

2017· article· en· W2735667632 on OpenAlexaff
Colin Baigent, William G. Herrington, Josef Coresh, Martin Landray, Adeera Levin, Vlado Perkovic, Marc A. Pfeffer, Peter Rossing, Michael Walsh, Christoph Wanner, David C. Wheeler, Wolfgang C. Winkelmayer­, John J.V. McMurray, Ali K. Abu‐Alfa, Patrick Archdeacon, Geoffrey A. Block, Fergus Caskey, Alfred K. Cheung, Bruce A. Cooper, Jonathan C. Craig, Laura M. Dember, Garabed Eknoyan, Ron T. Gansevoort, John S. Gill, Barbara S. Gillespie, Tom Greene, David C.H. Harris, Richard Haynes, Brenda R. Hemmelgarn, Charles A. Herzog, Thomas F. Hiemstra, Lesley A. Inker, Meg Jardine, Vivekanand Jha, Lixin Jiang, Kirsten L. Johansen, Reshma Kewalramani, Hiddo J.L. Heerspink, Martin Lefkowitz, Charmaine E. Lok, Fiona Loud, Romaldas Mačiulaitis, Dugan Maddux, Franklin W. Maddux, Magdalena Madero, Segundo Mariz, Michael Mauer, Joseph V. Nally, Masaomi Nangaku, Ikechi G. Okpechi, Patrick S. Parfrey, Roberto Pecoits‐Filho, Brian J.G. Pereira, Michael V. Rocco, Patrick Rossignol, Franz Schaefer, Francesca Tentori, Aliza Thompson, Marcello Tonelli, Allison Tong, Robert D. Toto, Katherine R. Tuttle, Thorsten Vetter, Angela Yee‐Moon Wang, Faı̈ez Zannad

Bibliographic record

VenueKidney International · 2017
Typearticle
Languageen
FieldMedicine
TopicRenal and Vascular Pathologies
Canadian institutionsHamilton Health SciencesMcMaster UniversityPopulation Health Research InstituteUniversity of British Columbia
FundersNational Institute of Diabetes and Digestive and Kidney DiseasesSteno Diabetes Center Copenhagen
KeywordsNephrologyMedicineKidney diseaseIntensive care medicineInternal medicineClinical trialMEDLINEDiseasePolitical science

Abstract

fetched live from OpenAlex

Despite the high costs of treatment of people with kidney disease and associated comorbid conditions, the amount of reliable information available to guide the care of such patients is very limited. Some treatments have been assessed in randomized trials, but most such trials have been too small to detect treatment effects of a magnitude that would be realistic to achieve with a single intervention. Therefore, KDIGO convened an international, multidisciplinary controversies conference titled "Challenges in the Conduct of Clinical Trials in Nephrology" to identify the key barriers to conducting trials in patients with kidney disease. The conference began with plenary talks focusing on the key areas of discussion that included appropriate trial design (covering identification and evaluation of kidney and nonkidney disease outcomes) and sensible trial execution (with particular emphasis on streamlining both design and conduct). Break out group discussions followed in which the key areas of agreement and remaining controversy were identified. Here we summarize the main findings from the conference and set out a range of potential solutions. If followed, these solutions could ensure future trials among people with kidney disease are sufficiently robust to provide reliable answers and are not constrained by inappropriate complexities in design or conduct.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.693
metaresearch head score (Gemma)0.680
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.307
Threshold uncertainty score0.378

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.6930.680
Meta-epidemiology (narrow)0.0040.004
Meta-epidemiology (broad)0.0070.011
Bibliometrics0.0050.005
Science and technology studies0.0100.021
Scholarly communication0.0390.033
Open science0.0130.023
Research integrity0.0560.110
Insufficient payload (model declined to judge)0.0050.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.405
GPT teacher head0.483
Teacher spread0.078 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designNot applicable
DomainMethods
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations147
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueKidney InternationalSame topicRenal and Vascular PathologiesFrench-language works237,207